中国组织工程研究 ›› 2025, Vol. 29 ›› Issue (35): 7519-7528.doi: 10.12307/2025.961

• 血管组织构建 vascular tissue construction • 上一篇    下一篇

蒙药蓝刺头对血管内皮细胞增殖和血管生成能力的潜在作用机制

方  源1,2,钱智勇3,何源哈达3,王海燕3,沙丽蓉1,李筱贺3,刘  婧4,贺雅超4,张  凯5,特木日巴根6   

  1. 内蒙古医科大学,1研究生院,3基础医学院人体解剖教研室,4巴彦淖尔临床医学院,内蒙古自治区呼和浩特市  010000;2内蒙古巴彦淖尔市医院,内蒙古自治区巴彦淖尔市  015000;5乌兰察布市第二医院骨科,内蒙古自治区乌兰察布市  012000;6呼和浩特市中医蒙医医院蒙医骨伤科,内蒙古自治区呼和浩特市  010000
  • 收稿日期:2024-10-09 接受日期:2024-12-12 出版日期:2025-12-18 发布日期:2025-04-30
  • 通讯作者: 王海燕,硕士,教授,硕士生导师,内蒙古医科大学基础医学院人体解剖教研室,内蒙古自治区呼和浩特市 010000 并列通讯作者:李筱贺,博士,教授,博士生导师,内蒙古医科大学基础医学院人体解剖教研室,内蒙古自治区呼和浩特市 010000
  • 作者简介:方源,女,1992年生,汉族,内蒙古自治区巴彦淖尔市人,内蒙古医科大学在读硕士,主治医师,主要从事生物3D打印方面的研究。
  • 基金资助:
    内蒙古自治区卫生健康科技项目(202201188),项目负责人:王海燕;内蒙古自治区高等学校创新团队发展计划项目(NMGIRT2419),项目负责人:王海燕;内蒙古自治区高等学校创新团队发展计划项目(NMGIRT2227),项目负责人:李筱贺;2021年内蒙古自治区蒙医药协同创新中心科学研究项目(MYYXTYB202104),项目负责人:李筱贺;内蒙古医科大学2021年度校级科研重点项目(YKD2021ZD001),项目负责人:李筱贺;2021年乌兰察布市科技基础研究项目(2021JC321),项目负责人:张凯;内蒙古自然科学基金项目(2022MS08051),项目负责人:特木日巴根

Mechanism of Mongolian medicine Echinops sphaerocephalus L. in proliferation and angiogenesis of vascular endothelial cells

Fang Yuan1, 2, Qian Zhiyong3, He Yuanhada3, Wang Haiyan3, Sha Lirong1, Li Xiaohe3, Liu Jing4, He Yachao4, Zhang Kai5, Temribagen6   

  1. 1Graduate School, 3Department of Human Anatomy, School of Basic Medicine, 4Bayannur Clinical College of Medicine, Inner Mongolia Medical University, Hohhot 010000, Inner Mongolia Autonomous Region, China; 2Bayannur Hospital, Bayannur 015000, Inner Mongolia Autonomous Region, China; 5Department of Orthopedics, The Second Hospital of Ulanqab, Ulanqab 012000, Inner Mongolia Autonomous Region, China; 6Department of Orthopedics and Traumatology, Hohhot TCM Mongolian Hospital, Hohhot 010000, Inner Mongolia Autonomous Region, China
  • Received:2024-10-09 Accepted:2024-12-12 Online:2025-12-18 Published:2025-04-30
  • Contact: Wang Haiyan, Master, Professor, Master’s supervisor, Department of Human Anatomy, School of Basic Medicine, Inner Mongolia Medical University, Hohhot 010000, Inner Mongolia Autonomous Region, China Co-corresponding author: Li Xiaohe, MD, Professor, Doctoral supervisor, Department of Human Anatomy, School of Basic Medicine, Inner Mongolia Medical University, Hohhot 010000, Inner Mongolia Autonomous Region, China
  • About author:Fang Yuan, Master candidate, Attending physician, Graduate School, Inner Mongolia Medical University, Hohhot 010000, Inner Mongolia Autonomous Region, China; Bayannur Hospital, Bayannur 015000, Inner Mongolia Autonomous Region, China
  • Supported by:
    Inner Mongolia Health Science and Technology Project, No. 202201188 (to WHY); Inner Mongolia Higher Education Innovation Team Development Plan, Nos. NMGIRT2419 (to WHY) and NMGIRT2227 (to LXH); Scientific Research Project of Mongolian Medicine Collaborative Innovation Center of Inner Mongolia Autonomous Region in 2021, No. MYYXTYB202104 (to LXH); Key Research Project of Inner Mongolia Medical University in 2021, No. YKD2021ZD001 (to LXH); 2021 Ulanqab Science and Technology Basic Research Project, No. 2021JC321 (to ZK); Inner Mongolia Natural Science Foundation Project, No. 2022MS08051 (to Temribagen)

摘要:


文题释义:
蒙药蓝刺头:蒙名乌日格苏图-呼和,在蒙医学中具有固骨、接骨、愈伤、止痛等疗效,临床上用于治疗筋伤骨折、骨不愈合、骨热、刺痛症、疮疡等疾病。
网络药理学:基于系统生物学理论,通过对生物网络进行系统性分析,筛选出特定信号节点,进而开展多靶点药物分子设计,形成了一个
新兴的交叉学科领域。网络药理学结合了系统生物学与多靶向药理学的理论,致力于将生物学网络与药物作用网络进行融合性研究,深入探讨药物与网络中的节点或模块之间的相互作用,从而实现了从传统单一靶点研究向全面网络分析的转变。

背景:蒙药蓝刺头对于筋伤骨折、骨不愈合、骨热、刺痛症、疮疡等疾病的疗效显著,是蒙医常用骨伤用药。课题组前期研究证实蒙药蓝刺头可促进骨髓间充质干细胞的增殖及成骨分化,但它对骨缺损修复过程中血管生成的影响尚未可知。
目的:利用人脐静脉血管内皮细胞进行体外细胞实验,探讨蓝刺头对血管生成的影响,利用网络药理学技术挖掘蓝刺头中可能存在的促进
血管形成的活性成分及其潜在作用机制。
方法:制备蓝刺头乙醇提取物并冻干保存。观察不同质量浓度(1 000,100,10 μg/mL)蓝刺头干预对人脐静脉内皮细胞增殖、迁移、趋化及血管生成能力的影响。利用网络药理学对蒙药蓝刺头中具有促血管生成作用的有效成分及可能信号通路进行富集和分析。
结果与结论:①蓝刺头对血管生成的影响受其质量浓度的调节:在低质量浓度(10 μg/mL)条件下,蓝刺头能够促进人脐静脉血管内皮细胞的增殖、迁移、趋化及血管生成;相反,在高质量浓度(1 000 μg/mL)下,蓝刺头抑制人脐静脉内皮细胞的增殖、迁移和趋化,由于实验时间的限制,高质量浓度蓝刺头对血管生成的抑制作用并不显著。10 μg/mL蓝刺头能够上调与血管生成相关因子(激酶插入域蛋白受体、血管内皮生长因A和缺氧诱导因子α)mRNA的表达,从而影响骨修复过程中的血管生成。②网络药理学分析表明,蓝刺头可能通过4种核心活性成分(芹菜素、咖啡酸、槲皮素和绿原酸)与8个核心靶点(TGFB1、TNF、IL-6、STAT3、CTNNB1、IL-1B、AKT1、HIF-1A)的结合,对血管生成、动脉粥样硬化、多种病毒感染以及肿瘤血管生成相关的信号通路产生影响。
https://orcid.org/0009-0008-4943-5917(方源)

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松;组织工程

关键词: 蓝刺头, 人脐静脉血管内皮细胞, 血管生成, 细胞增殖, 网络药理学, 工程化组织构建

Abstract: BACKGROUND: Mongolian medicine Echinops sphaerocephalus L. is a commonly used medicine for bone injury in Mongolian medicine. It is effective for tendon injury, fracture, bone nonunion, bone fever, tingling, sore and other diseases. Our previous studies have confirmed that Mongolian medicine Echinops sphaerocephalus L. can promote the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells, but its effect on angiogenesis in the process of bone defect repair is unknown.
OBJECTIVE: To investigate the effect of Echinops sphaerocephalus L. on in vitro angiogenesis in human umbilical vein vascular endothelial cells and to explore the angiogenesis-promoting active ingredients and their mechanisms of action of Echinops sphaerocephalus L. using network pharmacology technology.
METHODS: The ethanol extract of Echinops sphaerocephalus L. was prepared and preserved by freeze-drying. The proliferation, migration, chemotaxis and angiogenesis of human umbilical vein endothelial cells were observed after treatment with different concentrations (1 000, 100, and 10 μg/mL) of Echinops sphaerocephalus L. The active components and possible signaling pathways that promoted angiogenesis were enriched and analyzed by network pharmacology.
RESULTS AND CONCLUSION: (1) The effect of Echinops sphaerocephalus L. on angiogenesis was regulated by its mass concentration: at low mass concentration (10 μg/mL), Echinops sphaerocephalus L. could promote the proliferation, migration, chemotaxis and angiogenesis of human umbilical vein vascular endothelial cells; on the contrary, Echinops sphaerocephalus L. inhibited the proliferation, migration, and chemotaxis of human umbilical vein endothelial cells at high mass concentration (1 000 μg/mL). However, the inhibitory effect of Echinops sphaerocephalus L. on angiogenesis was not significant at high mass concentration due to the limitation of experimental time. 10 μg/mL Echinops sphaerocephalus L. could up-regulate the mRNA expression of angiogenesis-associated factors, including kinase insert domain receptor, vascular endothelial growth factor A, and hypoxia-inducible factor α, and thereby influenced angiogenesis during bone repair. (2) Network pharmacological analyses indicated that Echinops sphaerocephalus L. may bind to eight core targets (TGFB1, TNF, IL-6, STAT3, CTNNB1, IL-1B, AKT1, and HIF-1A) through four core active components (apigenin, caffeic acid, quercetin, and chlorogenic acid) to exert an effect on angiogenesis, atherosclerosis, multiple viral infections, and tumor angiogenesis-related signaling pathways.

Key words: Echinops sphaerocephalus L., human umbilical vein endothelial cells, angiogenesis, cell proliferation, network pharmacology, engineered tissue construction

中图分类号: